Edition:
United Kingdom

Clementia Pharmaceuticals Inc (CMTA.OQ)

CMTA.OQ on NASDAQ Stock Exchange Global Select Market

14.58USD
6:46pm GMT
Change (% chg)

$-0.36 (-2.41%)
Prev Close
$14.94
Open
$14.93
Day's High
$15.29
Day's Low
$14.54
Volume
21,119
Avg. Vol
17,864
52-wk High
$19.58
52-wk Low
$8.23

Chart for

About

Clementia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need. Its lead product candidate, palovarotene, is an oral small molecule that binds and... (more)

Overall

Beta: --
Market Cap(Mil.): $474.83
Shares Outstanding(Mil.): 29.68
Dividend: --
Yield (%): --

Financials

  CMTA.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -- -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

Earnings vs. Estimates